GlucoTrack (NASDAQ:GCTK) Stock Rating Lowered by Wall Street Zen

GlucoTrack (NASDAQ:GCTK) was downgraded by stock analysts at Wall Street Zen to a “strong sell” rating in a research report issued to clients and investors on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research report on Tuesday, April 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, GlucoTrack currently has a consensus rating of “Sell”.

GlucoTrack Trading Down 1.6%

Shares of NASDAQ:GCTK opened at $0.49 on Friday. The company has a market capitalization of $3.08 million, a PE ratio of -0.03 and a beta of 0.77. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.08. GlucoTrack has a 12-month low of $0.29 and a 12-month high of $14.14. The business’s fifty day simple moving average is $0.48 and its 200-day simple moving average is $1.36.

Institutional Investors Weigh In On GlucoTrack

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of America Corp DE boosted its stake in GlucoTrack by 102,125.0% in the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock valued at $25,000 after acquiring an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC acquired a new position in shares of GlucoTrack during the fourth quarter worth $52,000. Finally, Ikarian Capital LLC purchased a new stake in shares of GlucoTrack during the 4th quarter valued at $177,000. Hedge funds and other institutional investors own 10.92% of the company’s stock.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.